跳至主要内容
临床试验/NCT02977234
NCT02977234Unknown1 期

Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate in Patients With Hydrosalpinx

Ain Shams University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
40
试验地点
1
主要终点
Fallopian tubal occlusion in patients with hydrosalpinx.

研究概览

简要总结

The purpose of this study is to assess the effectiveness of hysteroscopic tubal application of Iso Amyl-2-cyanoacrylate in occluding uterine tubes of infertile women with hydrosalpinx, which would make it an easy approach for occluding tubes with hydrosalpinx prior to IVF.

详细描述

The study will be conducted according to the guidelines on human experimentation of the 1975 Declaration of Helsinki. For all patients after taking signed informed consent , transcervical hysteroscopic cannulation of the proximal one centimeter of fallopian tubes with hydrosalpinx, will be done using a 4 Fr, 42cm long, polyethylene ureteric catheter, where 0.5 ml of Iso Amyl-2-cyanoacrylate (AMCRYLATE®) will be injected.

All the surgical procedures will be performed without anesthesia, only premedication with an NSAID (e.g. NaproxenR) is given orally one hour before the procedure.

Each patient will be under close observation for the first 24 hours postprocedure for any signs of inflammation as abdominal pain, tenderness or fever and for the vital data.

Hysterosalpingography will be done for all patients 0ne and 3 months postinjection to confirm tubal occlusion prior to IVF.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
22 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Infertile women due to tubal factor with hydrosalpinx (unilateral or bilateral) prepared for IVF.

排除标准

  • Acute Pelvic inflammatory disease.
  • Intra uterine pathology

研究组 & 干预措施

Iso-Amyl 2-Cyano Acrylate

Experimental

Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx

干预措施: Isoamyl 2-Cyanoacrylate (Drug)

结局指标

主要结局

Fallopian tubal occlusion in patients with hydrosalpinx.

时间窗: from one to three months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed I Amer

Professor

Ain Shams University

研究点 (1)

Loading locations...

相似试验